| Dimension Goal | Implementation Question | Hypothesis |
---|---|---|---|
Reach | Who is intended to benefit? | How do we reach reproductive-aged women in rural kenya? | A screening strategy offered through community health campaigns in a central location will reach a large proportion of reproductive-aged women. |
How do we reach them? | |||
Effectiveness | Is the program effective? | Are women getting screened for cervical cancer with HPV? | A community-based strategy allowing for self-testing will be highly acceptable. |
How do we ensure effectiveness? | Are HPV + women successfully linking to treatment? | Innovative, patient and provider-designed strategies will increase the number of women linking to care. | |
Adoption and Maintenance | How can strategy be maintained after initial implementation and adopted in similar communities? | What are the patient, provider and delivery system processes necessary to ensure consistent service provision? | A screening protocol with a simple, patient-performed test offered as part of a health fair will minimize the costs to the health care system to introduce screening. |
What are the short and long-term health effects in the community? | What is the population-level health impact of screening using HPV self-testing in the CHCs with enhanced linkage to care? | The high number of at -risk women reached through the CHC-base strategy with enhanced linkage to care would produce a greater population-level health impact. | |
Implementation | What is adherence to the implementation strategy at the delivery level? | Is HPV testing being offered and delivered consistently at the CHC and clinic sites? | Providing testing in a high-volume CHC will reach a large number of women with low staffing and infrastructure needs, and will therefore have a lower cost per woman treated than a standard strategy. |
What are the costs of implementation? | What is the cost per lesion treated? |